Immediate Impact
1 by Nobel laureates 31 hit
Citing Papers
Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story
2023 Hit
The JAK-STAT pathway at 30: Much learned, much more to do
2022 Hit
Works of Mary C. Riedy being referenced
Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid Development
1995 Hit